Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02476565 · ClinicalTrials.gov registry record · NA
Comparison of Endotracheal Intubation Over the Aintree Via the I-gel and Laryngeal Mask Airway Supreme
A NA study of Difficult Intubation, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
- 2
- Study locations
NCT02476565 is a NA study of Difficult Intubation that has completed, run by Vanderbilt University. The registered enrollment target is 39 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT02476565, a NA study of Difficult Intubation, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
- 2
- Study locations
Study Summary
The investigators plan to conduct a randomized trial comparing the efficacy of intubating the tracheal using an Aintree intubation catheter through either the LMA-S or I-gel supraglottic devices
Conditions Studied
Interventions
- DEVICE LMA-Supreme supraglottic device
- DEVICE I-gel supraglottic device
Study Locations (2)
Tennessee
- Vanderbilt University Medical Center - Nashville
Texas
- South Texas Veterans HealthCare System - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02476565
The ClinicalTrials.gov registry entry for NCT02476565 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Difficult Intubation appearing as the primary indexed condition, and to 2 interventions - of which LMA-Supreme supraglottic device is the first listed.
NCT02476565 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Tennessee, Texas.
Frequently Asked Questions
What is clinical trial NCT02476565 about?
NCT02476565 is a clinical study titled "Comparison of Endotracheal Intubation Over the Aintree Via the I-gel and Laryngeal Mask Airway Supreme". The investigators plan to conduct a randomized trial comparing the efficacy of intubating the tracheal using an Aintree intubation catheter through either the LMA-S or I-gel supraglottic devices
What is the current status of trial NCT02476565?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2014-09. Estimated completion is 2016-09.
What conditions does trial NCT02476565 study?
This clinical trial studies the following conditions: Difficult Intubation.
What interventions are being tested in trial NCT02476565?
The interventions under investigation include: LMA-Supreme supraglottic device (DEVICE), I-gel supraglottic device (DEVICE).
Who is sponsoring clinical trial NCT02476565?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02476565 being conducted?
This trial has 2 study locations across Tennessee, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Difficult Intubation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.